LivaNova (LIVN) Divestments (2018 - 2021)

LivaNova's (LIVN) quarterly Divestments came in at -$43000.0 in Q2 2021, down 100.02% quarter-over-quarter from $173.4 million in Q2 2018.

LivaNova (LIVN) Divestments (2018 - 2021) Analysis & Trends

LivaNova has disclosed Divestments across 2 years of filings, most recently posting -$43000.0 for Q2 2021.

  • Divestments for Q2 2021 came in at -$43000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was -$43000.0 (changed 0.0% YoY), and the FY2021 annual result was $23.1 million, changed N/A from the prior year.
  • Divestments came in at -$43000.0 for Q2 2021 at LivaNova, down from $173.4 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $173.4 million in Q2 2018 to a low of -$43000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.37 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 LivaNova 4.29 Bn 3.71 Bn 243.75 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 -43,000.00
Jun 30, 2018 173.38 Mn